STOCK TITAN

Danaher (DHR) CFO Matthew Gugino details stock, options and deferred units

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
3

Rhea-AI Filing Summary

Danaher Corporation executive Matthew E. Gugino, EVP & Chief Financial Officer, filed an initial ownership report showing his existing equity interests in Danaher common stock and related compensation plans. The filing lists deferred compensation tied to a Danaher stock fund, multiple employee stock options that vest over several years, and common shares held directly and through a 401(k) plan. The notional deferred compensation shares convert on a one-for-one basis into Danaher common stock under the company’s deferred compensation program.

Positive

  • None.

Negative

  • None.
Insider Gugino Matthew E
Role EVP & Chief Financial Officer
Type Security Shares Price Value
holding Danaher Deferred Compensation Programs - Danaher Stock Fund -- -- --
holding Employee stock option (right to buy) -- -- --
holding Employee stock option (right to buy) -- -- --
holding Employee stock option (right to buy) -- -- --
holding Employee stock option (right to buy) -- -- --
holding Employee stock option (right to buy) -- -- --
holding Employee stock option (right to buy) -- -- --
holding Employee stock option (right to buy) -- -- --
holding Employee stock option (right to buy) -- -- --
holding Employee stock option (right to buy) -- -- --
holding Employee stock option (right to buy) -- -- --
holding Employee stock option (right to buy) -- -- --
holding Employee stock option (right to buy) -- -- --
holding Employee stock option (right to buy) -- -- --
holding Common Stock -- -- --
holding Common Stock -- -- --
Holdings After Transaction: Danaher Deferred Compensation Programs - Danaher Stock Fund — 904.67 shares (Direct); Employee stock option (right to buy) — 4,210 shares (Direct); Common Stock — 7,644 shares (Direct); Common Stock — 112.137 shares (Indirect, By 401(k))
Footnotes (1)
  1. Represents the participant's and/or Company contributions to the Danaher stock fund in the reporting person's account under one or more of the plans that form part of Danaher's deferred compensation program. The reported securities reflect unfunded, notional shares of Danaher common stock calculated based on the closing price of Danaher common stock as reported on the NYSE on the date such compensation is credited. The vesting terms and manner and form of distribution of amounts contributed or deferred under the program are based upon the provisions of the respective plan, which provisions are summarized in the latest Danaher Corporation annual meeting proxy statement on Schedule 14A as filed with the Securities and Exchange Commission. The notional shares convert on a one-for-one basis. Date shown is grant date. Twenty percent of the options became or become exercisable on each of the first five anniversaries of the grant date. Date shown is grant date. Twenty-five percent of the options became or become exercisable on each of the first four anniversaries of the grant date. Date shown is grant date. Fifty percent of the options became or become exercisable on each of the third and fourth anniversaries of the grant date.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
Gugino Matthew E

(Last) (First) (Middle)
2200 PENNSYLVANIA AVE NW
SUITE 800W

(Street)
WASHINGTON DC 20037

(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
02/28/2026
3. Issuer Name and Ticker or Trading Symbol
DANAHER CORP /DE/ [ DHR ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
EVP & Chief Financial Officer
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock 7,644 D
Common Stock 112.137 I By 401(k)
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Danaher Deferred Compensation Programs - Danaher Stock Fund(1) (2) (2) Common Stock 904.67 (3) D
Employee stock option (right to buy) 02/24/2017(4) 02/24/2027 Common Stock 4,210 $76.47 D
Employee stock option (right to buy) 02/24/2018(4) 02/24/2028 Common Stock 3,478 $88.24 D
Employee stock option (right to buy) 02/24/2019(4) 02/24/2029 Common Stock 3,309 $100.81 D
Employee stock option (right to buy) 11/15/2019(4) 11/15/2029 Common Stock 1,339 $127.02 D
Employee stock option (right to buy) 02/24/2020(4) 02/24/2030 Common Stock 3,343 $139.3 D
Employee stock option (right to buy) 02/24/2021(4) 02/24/2031 Common Stock 7,430 $198.09 D
Employee stock option (right to buy) 02/24/2021(4) 02/24/2031 Common Stock 2,420 $198.09 D
Employee stock option (right to buy) 02/24/2022(5) 02/24/2032 Common Stock 2,221 $241.22 D
Employee stock option (right to buy) 11/15/2022(6) 11/15/2032 Common Stock 5,079 $240.13 D
Employee stock option (right to buy) 02/24/2023(5) 02/24/2033 Common Stock 2,535 $221.29 D
Employee stock option (right to buy) 03/01/2024(5) 03/01/2034 Common Stock 1,931 $255.87 D
Employee stock option (right to buy) 03/01/2025(5) 03/01/2035 Common Stock 5,158 $207.76 D
Employee stock option (right to buy) 11/15/2025(5) 11/15/2035 Common Stock 10,410 $221.21 D
Explanation of Responses:
1. Represents the participant's and/or Company contributions to the Danaher stock fund in the reporting person's account under one or more of the plans that form part of Danaher's deferred compensation program. The reported securities reflect unfunded, notional shares of Danaher common stock calculated based on the closing price of Danaher common stock as reported on the NYSE on the date such compensation is credited.
2. The vesting terms and manner and form of distribution of amounts contributed or deferred under the program are based upon the provisions of the respective plan, which provisions are summarized in the latest Danaher Corporation annual meeting proxy statement on Schedule 14A as filed with the Securities and Exchange Commission.
3. The notional shares convert on a one-for-one basis.
4. Date shown is grant date. Twenty percent of the options became or become exercisable on each of the first five anniversaries of the grant date.
5. Date shown is grant date. Twenty-five percent of the options became or become exercisable on each of the first four anniversaries of the grant date.
6. Date shown is grant date. Fifty percent of the options became or become exercisable on each of the third and fourth anniversaries of the grant date.
Remarks:
Exhibit List: Exhibit 24 - Power of Attorney
/s/ James F. O'Reilly, attorney-in-fact for Matthew E. Gugino 03/02/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What does Danaher (DHR) disclose in Matthew Gugino’s Form 3 filing?

The Form 3 shows Matthew E. Gugino’s existing ownership in Danaher equity, including deferred compensation units, employee stock options, and common shares. It establishes his baseline holdings as EVP & Chief Financial Officer under SEC insider reporting rules.

What deferred compensation holdings does Matthew Gugino report in Danaher (DHR) stock?

Gugino reports interests in Danaher deferred compensation programs invested in a Danaher stock fund. These are unfunded, notional shares of Danaher common stock, calculated using the NYSE closing price when compensation is credited, and convert on a one-for-one basis.

What stock options are reported in Matthew Gugino’s Danaher (DHR) Form 3?

The filing lists several employee stock options

How many Danaher (DHR) common shares does Matthew Gugino hold directly and indirectly?

The Form 3 reports 7,644 shares of common stock112.137 shares

How are Danaher (DHR) deferred compensation stock units calculated for Matthew Gugino?

Deferred compensation units are notional Danaher shares